Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

330
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
330
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

352
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
352
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Acute Pharyngitis01:30

Acute Pharyngitis

1.6K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
1.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

559
The pathophysiology of pneumonia involves the following steps:
559
The Bronchial Tree01:23

The Bronchial Tree

3.6K
The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Evaluating current bronchiectasis care in Italy according to the 2025 European respiratory society recommendations.

Therapeutic advances in respiratory disease·2026
Same author

The importance of symptoms in bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adults.

The European respiratory journal·2026
Same author

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

The European respiratory journal·2026
Same author

Bronchiectasis in Italy: an analysis of the EMBARC registry.

ERJ open research·2026

Related Experiment Video

Updated: Sep 12, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K

Haemophilus influenzae in bronchiectasis.

Alessandro De Angelis1,2, Martina Marchello3,4, Angela Tramontano5,6

  • 1Department of Biomedical Sciences, Humanitas University, Milan, Italy.

European Respiratory Review : an Official Journal of the European Respiratory Society
|August 6, 2025
PubMed
Summary

Haemophilus influenzae is a common pathogen in bronchiectasis, but its exact role in disease progression is unclear. Further research is needed to understand its impact and guide treatment strategies for this chronic respiratory condition.

More Related Videos

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
09:56

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

10.4K
Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions
08:12

Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions

Published on: September 2, 2011

11.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.3K
Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation
09:56

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

10.4K
Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions
08:12

Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions

Published on: September 2, 2011

11.7K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Bronchiectasis is a chronic respiratory disease marked by irreversible bronchial dilation and recurrent infections.
  • Haemophilus influenzae is frequently detected in bronchiectasis patients, employing various virulence factors to establish persistent infections.
  • The specific impact of H. influenzae on bronchiectasis pathophysiology and progression remains incompletely understood compared to other airway diseases.

Purpose of the Study:

  • To review the impact of Haemophilus influenzae on bronchiectasis pathophysiology and disease progression.
  • To compare the role of H. influenzae in bronchiectasis with its role in other chronic respiratory diseases.
  • To highlight the need for further investigation into H. influenzae's contribution to bronchiectasis morbidity.

Main Methods:

  • Literature review of studies on Haemophilus influenzae in bronchiectasis and other chronic respiratory diseases.
  • Analysis of virulence mechanisms of H. influenzae, including adhesion, invasion, biofilm formation, and antibiotic resistance.
  • Examination of current treatment guidelines and their implications for H. influenzae management in bronchiectasis.

Main Results:

  • H. influenzae utilizes multiple virulence factors to persist in the respiratory tract and evade host defenses.
  • Current guidelines do not recommend H. influenzae eradication therapy in bronchiectasis, unlike for Pseudomonas aeruginosa.
  • Macrolide treatment for chronic H. influenzae infection carries risks of antibiotic resistance and P. aeruginosa enrichment.
  • Competitive interactions between H. influenzae and P. aeruginosa may influence microbiome dynamics and clinical outcomes.

Conclusions:

  • The precise role of H. influenzae in bronchiectasis morbidity and progression requires further elucidation.
  • Current evidence is insufficient to support vaccination against nontypeable H. influenzae in chronic airway diseases.
  • Understanding H. influenzae's impact is crucial for developing effective management strategies for bronchiectasis patients.